NYSIF: 31% of COVID Claimants Suffer Long-Term Illness, but Rate Declining

Written By Delainne Bond

ProMedView Strategic Clinical Solutions continues to gather information about Neuro COVID and resources for those experiencing post COVID condition.

A report released by New York State Insurance Fund found that 31% of workers who filed claims for COVID-19 continued medical treatment or took time off work more than 60 days after the initial infection. This article provides insights into the demographics of those affected and the claims outcomes.

SOURCE New York State Insurance Fund

NYSIF REPORT EXECUTIVE SUMMARY EXCERPT First, Long Covid is an emerging threat to public health with ongoing, cascading, and yet unclear implications for employers, households, individuals, and the economy. Indeed, with each passing day, the number of people affected by Long Covid grows, and with it, the need to understand the condition and its effects. Second, reliable data is lacking, which, together with the subjective and wide-ranging nature of symptoms across numerous organ systems, makes defining, diagnosing, and researching Long Covid a formidable challenge.

This report seeks to leverage NYSIF’s data to contribute to the broader research on Long Covid. It analyzes the more than 3,000 established Covid-19 workers’ compensation claims NYSIF received between January 1, 2020, and March 31, 2022, to ascertain:

  1. How many claimants developed Long Covid.

  2. The most common symptoms they suffered.

  3. Claimants’ experience getting back to everyday work life.

  4. How Long Covid has affected various claimant groups, including women, older adults, those hospitalized for their initial infection, those with comorbidities, and essential workers.

Early diagnosis and early intervention are the keys to minimizing these risks. ProMedView has workforce resources and solutions to mitigate the risks associated with COVID and COVID complications.

Delainne Bond

Delainne Bond, BSN, RN, holds dual degrees in Nursing and Neuropsychology. She is the Principal Consultant with ProMedView, Founder of the covidCAREgroup, and a PRIMA Board Member with the Tampa, Florida chapter.

Recognized as a leader in clinical solutions for complex injuries and illnesses, Delainne has a broad spectrum of clinical experience including Workers’ Compensation, acute and critical care in the hospital setting, occupational medicine, and community health.

In the national Workers’ Compensation arena, Delainne is a CEU Educator, and her experience includes leadership, risk management, catastrophic case management, mass casualty incident response, critical incident management, and provider network development.

Since the event of the pandemic, Delainne has devoted her clinical expertise to researching Long COVID, offering education and resources on a global scale through the covidCAREgroup.

In addition to educating providers, clinicians, attorneys, case managers, and nurses, Delainne has published many articles about Long COVID with ~6 million views in 2022. She runs the largest clinical social media support groups in the world with followers and collaborators including physicians, clinicians, and business leaders from 110 countries.

https://www.promedview.com
Previous

WORKFORCE WELLNESS RISK FORECAST REPORT - RAIsonance, Fall 2023
Next

Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms